SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS

The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure...

Full description

Saved in:
Bibliographic Details
Main Authors SANDNER, Peter, WEBSTER, Robert, Alan, STELLFELD, Timo, BOULTADAKIS-ARAPINIS, Melissa, MATHAR, Ilka, COLLIN-KRÖPELIN, Marie-Pierre, DIETZ, Lisa, SCHMECK, Carsten, WUNDER, Frank, MONDRITZKI, Thomas, HOFMEISTER, Lucas, Hudson, DIESKAU, Andre, CANDISH, Lisa, VAKALOPOULOS, Alexandros, ORTEGA HERNANDEZ, Nuria
Format Patent
LanguageEnglish
French
German
Published 18.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF), hypertension (HTN), peripheral arterial diseases (PAD, PAOD), cardio-renal and kidney diseases, preferably chronic and diabetic kidney disease (CKD and DKD), cardiopulmonary and lung diseases, preferable pulmonary hypertension (PH), and other diseases, preferably neurodegenerative diseases and different forms of dementias, fibrotic diseases, systemic sclerosis (SSc), sickle cell disease (SCD), wound healing disorders such as diabetic foot ulcer (DFU).
AbstractList The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular and cardiac diseases, preferably heart failure with reduced and preserved ejection fraction (HFrEF and HFpEF), hypertension (HTN), peripheral arterial diseases (PAD, PAOD), cardio-renal and kidney diseases, preferably chronic and diabetic kidney disease (CKD and DKD), cardiopulmonary and lung diseases, preferable pulmonary hypertension (PH), and other diseases, preferably neurodegenerative diseases and different forms of dementias, fibrotic diseases, systemic sclerosis (SSc), sickle cell disease (SCD), wound healing disorders such as diabetic foot ulcer (DFU).
Author DIESKAU, Andre
STELLFELD, Timo
SANDNER, Peter
WEBSTER, Robert, Alan
VAKALOPOULOS, Alexandros
BOULTADAKIS-ARAPINIS, Melissa
COLLIN-KRÖPELIN, Marie-Pierre
MONDRITZKI, Thomas
CANDISH, Lisa
DIETZ, Lisa
MATHAR, Ilka
SCHMECK, Carsten
ORTEGA HERNANDEZ, Nuria
HOFMEISTER, Lucas, Hudson
WUNDER, Frank
Author_xml – fullname: SANDNER, Peter
– fullname: WEBSTER, Robert, Alan
– fullname: STELLFELD, Timo
– fullname: BOULTADAKIS-ARAPINIS, Melissa
– fullname: MATHAR, Ilka
– fullname: COLLIN-KRÖPELIN, Marie-Pierre
– fullname: DIETZ, Lisa
– fullname: SCHMECK, Carsten
– fullname: WUNDER, Frank
– fullname: MONDRITZKI, Thomas
– fullname: HOFMEISTER, Lucas, Hudson
– fullname: DIESKAU, Andre
– fullname: CANDISH, Lisa
– fullname: VAKALOPOULOS, Alexandros
– fullname: ORTEGA HERNANDEZ, Nuria
BookMark eNrjYmDJy89L5WQwCA51Cg7xDAkNcXVRCIgMcozy9_FXCPAMcA3ydPH0c1Vwdgxy8o-I9PF0VnB09nQJ5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJkamlmaGpo6GxkQoAQAQqiga
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate SUBSTITUIERTE PYRAZOLO-PIPERIDIN-CARBONSÄUREN
ACIDES PYRAZOLO PIPÉRIDINE CARBOXYLIQUES SUBSTITUÉS
ExternalDocumentID EP4259615A1
GroupedDBID EVB
ID FETCH-epo_espacenet_EP4259615A13
IEDL.DBID EVB
IngestDate Fri Oct 25 05:46:09 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
German
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_EP4259615A13
Notes Application Number: EP20210820285
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231018&DB=EPODOC&CC=EP&NR=4259615A1
ParticipantIDs epo_espacenet_EP4259615A1
PublicationCentury 2000
PublicationDate 20231018
PublicationDateYYYYMMDD 2023-10-18
PublicationDate_xml – month: 10
  year: 2023
  text: 20231018
  day: 18
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies Bayer Aktiengesellschaft
RelatedCompanies_xml – name: Bayer Aktiengesellschaft
Score 3.4959662
Snippet The invention relates to substituted pyrazolo piperidine carboxylic acids, their salts and to processes for their preparation, and also to their use for...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231018&DB=EPODOC&locale=&CC=EP&NR=4259615A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401ag3rRrrKxwMN2K3hVIOxMACKaaFDQ9DvTQsQtJLbSzGv-8sodWL3ja7yb6y38x8szO7AA-lgVKRDHNlaGjCdZMXCh8YXMknIzU3Cp2TUiQKz4PxNFWfMy3rwGqXC9O8E_rVPI6IiCoQ73Ujrzc_Tiynia3cPvIVVr0_eYnpyC07FsYKwtmxTZeFTkhlSrEkB5GJR9NA5W0hUTpAK1oXYHBfbJGUsvmtUbxTOGTY2bo-g0657sEx3X281oOjeXvfjcUWettzGMSpHSd-kqKokdgisl7DWSgxnyETc_zAlagV2WG2mPlUsqjvxBcgeW5CpwoOvdwvc-my_SRHl9BF9l9egaSRSYUcjHOd5-obqQxVb0JZcpUUY70ifej_2c31P203cCL2S4hhMrmFbv3xWd6hfq35fbMz3xNdel0
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXWJwfDjdhtocCBGFhoQHmFUkO9NCylSS-1sRj_vrOEVi962-wm-8p-M_PNzuwCPJQ6SkUyyKWBrnDXTV5IrK8zKdeGcq4XKiMlTxQOwpE7lZ8zJWvBapcLU78T-lU_joiIKhDvVS2vNz9OLLuOrdw-shVWvT-NU8MWG3bMjRWEs20ZThzZERUpxZIYJgYeTR2Vt4lE6QAtbJWDwXm1eFLK5rdGGZ_AYYydratTaJXrLnTo7uO1LhwFzX03Fhvobc-gP5lak9RLpyhqhHiWmG-RHwmxFyMTs73QEaiZWFE28z0qmNSzJ-cgjJ2UuhIOPd8vc-7E-0kOL6CN7L-8BEEh2hI5GGMqy-UFWeqyWoey5DIpRuqS9KD3ZzdX_7TdQ8dNA3_ue-HLNRzzveMimWg30K4-Pstb1LUVu6t36Rv7cH1Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUBSTITUTED+PYRAZOLO+PIPERIDINE+CARBOXYLIC+ACIDS&rft.inventor=SANDNER%2C+Peter&rft.inventor=WEBSTER%2C+Robert%2C+Alan&rft.inventor=STELLFELD%2C+Timo&rft.inventor=BOULTADAKIS-ARAPINIS%2C+Melissa&rft.inventor=MATHAR%2C+Ilka&rft.inventor=COLLIN-KR%C3%96PELIN%2C+Marie-Pierre&rft.inventor=DIETZ%2C+Lisa&rft.inventor=SCHMECK%2C+Carsten&rft.inventor=WUNDER%2C+Frank&rft.inventor=MONDRITZKI%2C+Thomas&rft.inventor=HOFMEISTER%2C+Lucas%2C+Hudson&rft.inventor=DIESKAU%2C+Andre&rft.inventor=CANDISH%2C+Lisa&rft.inventor=VAKALOPOULOS%2C+Alexandros&rft.inventor=ORTEGA+HERNANDEZ%2C+Nuria&rft.date=2023-10-18&rft.externalDBID=A1&rft.externalDocID=EP4259615A1